Lupus Erythematosus, Systemic
"Lupus Erythematosus, Systemic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.
Descriptor ID |
D008180
|
MeSH Number(s) |
C17.300.480 C20.111.590
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Lupus Erythematosus, Systemic".
Below are MeSH descriptors whose meaning is more specific than "Lupus Erythematosus, Systemic".
This graph shows the total number of publications written about "Lupus Erythematosus, Systemic" by people in this website by year, and whether "Lupus Erythematosus, Systemic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 1 | 0 | 1 |
1997 | 1 | 1 | 2 |
1998 | 0 | 1 | 1 |
1999 | 1 | 1 | 2 |
2000 | 3 | 0 | 3 |
2001 | 1 | 0 | 1 |
2002 | 0 | 1 | 1 |
2003 | 2 | 1 | 3 |
2004 | 6 | 1 | 7 |
2005 | 3 | 0 | 3 |
2006 | 2 | 0 | 2 |
2007 | 5 | 2 | 7 |
2008 | 5 | 2 | 7 |
2009 | 4 | 3 | 7 |
2010 | 8 | 0 | 8 |
2011 | 6 | 2 | 8 |
2012 | 3 | 1 | 4 |
2013 | 7 | 0 | 7 |
2014 | 3 | 1 | 4 |
2015 | 7 | 0 | 7 |
2016 | 6 | 0 | 6 |
2017 | 4 | 1 | 5 |
2019 | 3 | 4 | 7 |
2020 | 4 | 0 | 4 |
2021 | 5 | 1 | 6 |
2022 | 11 | 0 | 11 |
2023 | 9 | 0 | 9 |
To return to the timeline,
click here.
Below are the most recent publications written about "Lupus Erythematosus, Systemic" by people in Profiles.
-
Faslpr gene dosage tunes the extent of lymphoproliferation and T cell differentiation in lupus. Clin Immunol. 2024 Jan; 258:109874.
-
Allogeneic cord blood regulatory T cells decrease dsDNA antibody and improve albuminuria in systemic lupus erythematosus. Front Immunol. 2023; 14:1217121.
-
V-Set Immunoglobulin Domain-Containing Protein 4 as a Novel Serum Biomarker of Lupus Nephritis and Renal Pathology Activity. Arthritis Rheumatol. 2023 09; 75(9):1573-1585.
-
Knowledge is power: regarding SMFM Consult Series #64: Systemic lupus erythematosus in pregnancy. Am J Obstet Gynecol. 2023 10; 229(4):361-363.
-
Ezh2 Knockout in B Cells Impairs Plasmablast Differentiation and Ameliorates Lupus-like Disease in MRL/lpr Mice. Arthritis Rheumatol. 2023 08; 75(8):1395-1406.
-
Pathogenic cellular and molecular mediators in lupus nephritis. Nat Rev Nephrol. 2023 08; 19(8):491-508.
-
Immunosuppression for the treatment of pulmonary hypertension in patients with systemic lupus erythematosus: A?systematic review. Int J Rheum Dis. 2023 Jun; 26(6):1022-1028.
-
Impact of follow-up adherence on disease activity in childhood-onset systemic lupus erythematosus (cSLE). Lupus. 2023 May; 32(6):799-803.
-
Distinct gene dysregulation patterns herald precision medicine potentiality in systemic lupus erythematosus. J Autoimmun. 2023 04; 136:103025.
-
Urinary CD163 is a marker of active kidney disease in childhood-onset lupus nephritis. Rheumatology (Oxford). 2023 03 01; 62(3):1335-1342.